DE69832115D1 - Verfahren zum Stabilisieren von Arylcarbonsäuren, dafür verwendbarer Stabilisator und eine stabilisierte Carbonsäure enthaltende wässrige Lösung - Google Patents

Verfahren zum Stabilisieren von Arylcarbonsäuren, dafür verwendbarer Stabilisator und eine stabilisierte Carbonsäure enthaltende wässrige Lösung

Info

Publication number
DE69832115D1
DE69832115D1 DE69832115T DE69832115T DE69832115D1 DE 69832115 D1 DE69832115 D1 DE 69832115D1 DE 69832115 T DE69832115 T DE 69832115T DE 69832115 T DE69832115 T DE 69832115T DE 69832115 D1 DE69832115 D1 DE 69832115D1
Authority
DE
Germany
Prior art keywords
aqueous solution
stabilizing
stabilized
carboxylic acid
containing aqueous
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69832115T
Other languages
English (en)
Other versions
DE69832115T2 (de
Inventor
Sawa Shirou
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Senju Pharmaceutical Co Ltd
Original Assignee
Senju Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Senju Pharmaceutical Co Ltd filed Critical Senju Pharmaceutical Co Ltd
Publication of DE69832115D1 publication Critical patent/DE69832115D1/de
Application granted granted Critical
Publication of DE69832115T2 publication Critical patent/DE69832115T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0046—Ear
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0043—Nose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Otolaryngology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
DE69832115T 1997-02-04 1998-02-03 Verfahren zum Stabilisieren von Arylcarbonsäuren, dafür verwendbarer Stabilisator und eine stabilisierte Carbonsäure enthaltende wässrige Lösung Expired - Lifetime DE69832115T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2180597 1997-02-04
JP2180597 1997-02-04

Publications (2)

Publication Number Publication Date
DE69832115D1 true DE69832115D1 (de) 2005-12-01
DE69832115T2 DE69832115T2 (de) 2006-07-13

Family

ID=12065276

Family Applications (2)

Application Number Title Priority Date Filing Date
DE69819569T Expired - Lifetime DE69819569D1 (de) 1997-02-04 1998-02-03 Verfahren zum Stabilisieren von Arylcarbonsäuren, dafür verwendbaren Stabilisator und eine stabilisierte Carbonsäure enthaltende wässrige Lösung
DE69832115T Expired - Lifetime DE69832115T2 (de) 1997-02-04 1998-02-03 Verfahren zum Stabilisieren von Arylcarbonsäuren, dafür verwendbarer Stabilisator und eine stabilisierte Carbonsäure enthaltende wässrige Lösung

Family Applications Before (1)

Application Number Title Priority Date Filing Date
DE69819569T Expired - Lifetime DE69819569D1 (de) 1997-02-04 1998-02-03 Verfahren zum Stabilisieren von Arylcarbonsäuren, dafür verwendbaren Stabilisator und eine stabilisierte Carbonsäure enthaltende wässrige Lösung

Country Status (7)

Country Link
US (3) US6274592B1 (de)
EP (2) EP0856310B1 (de)
KR (1) KR100506484B1 (de)
AT (2) ATE307610T1 (de)
CA (1) CA2228536A1 (de)
DE (2) DE69819569D1 (de)
ES (1) ES2250814T3 (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2321042T3 (es) 1997-09-15 2009-06-01 THE PROCTER & GAMBLE COMPANY Quinolonas antimicrobianas, composiciones y usos de las mismas.
US6387928B1 (en) 1997-09-15 2002-05-14 The Procter & Gamble Co. Antimicrobial quinolones, their compositions and uses
US6211246B1 (en) * 1999-06-10 2001-04-03 Mcneil-Ppc, Inc. Rapidly absorbed liquid compositions
AU2002354575A1 (en) 2001-07-12 2003-01-29 Bristol-Myers Squibb Pharma Company Tetrahydropurinones as corticotropin releasing factor
RU2004112787A (ru) 2001-09-26 2005-10-10 Байер Фармасьютикалс Корпорейшн (US) Производные 1,6-нафтиридина как противодиабетические средства
US8129431B2 (en) 2003-01-21 2012-03-06 Senju Pharmaceutical Co., Ltd. Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid
WO2007110835A2 (en) 2006-03-28 2007-10-04 The Procter & Gamble Company A coupling process for preparing quinolone intermediates
PL2001862T3 (pl) 2006-03-28 2011-09-30 Warner Chilcott Co Llc Jabłczany oraz odmiany polimorficzne kwasu (3S,5S)-7-[3-amino-5-metylo-piperydynylo]-1-cyklopropylo-1,4-dihydro-8-metoksy-4-okso-3-chinolinokarboksylowego
EP1999106B1 (de) 2006-03-28 2012-06-27 TaiGen Biotechnology Co., Ltd. Hybridreduktionsverfahren zur herstellung von chinolon-zwischenverbindungen
MX341189B (es) 2011-01-18 2016-08-09 Senju Pharma Co Composicion liquida y acousa de bromfenaco, que tiene efectividad conservadora.
WO2013031935A1 (ja) * 2011-08-31 2013-03-07 興和株式会社 安定な医薬組成物
DK4426434T3 (da) 2021-11-02 2025-11-10 Flare Therapeutics Inc Pparg inverse agonists and uses thereof
JP2025513455A (ja) 2022-04-22 2025-04-24 バーテックス ファーマシューティカルズ インコーポレイテッド 疼痛の治療のためのヘテロアリール化合物

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB873526A (en) 1957-08-14 1961-07-26 Upjohn Co Fluid compositions comprising (acetyl-salicylic acid)-anhydride
US4339428A (en) 1980-08-18 1982-07-13 Bristol-Myers Company Capsule product containing high dosage of aspirin in powder or granulated form and alkaline tablet or pellet comprising magnesium carbonate, calcium carbonate and a magnesium dry component
US4559343A (en) 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
HU195918B (en) 1984-03-14 1988-08-29 Jerome Corbiere Process for producing pharmaceutical compositions containing non-steroide antiflogistic active components
IL80459A (en) 1986-10-30 1991-04-15 Abic Ltd Water-soluble adduct of norfloxacin and nicotinic acid
IT1226940B (it) 1988-09-16 1991-02-22 Recordati Chem Pharm Sistema terapeutico a rilascio controllato per formulazioni farmaceutiche liquide
CA1336687C (en) 1989-08-23 1995-08-15 Thomas M. Tencza Process for preparing tablets containing ibuprofen, apap and caffeine, the products of this process and the use of such products
US5296228A (en) 1992-03-13 1994-03-22 Allergan, Inc. Compositions for controlled delivery of pharmaceutical compounds
ES2065846B1 (es) * 1993-04-20 1995-10-01 Cusi Lab Formulacion farmaceutica a base de un agente antiinflamatorio esteroidico o no esteroidico y un antibiotico pertenciente al grupo de los inhibidores de la adn girasa para su utilizacion topica oftalmica.
DE69417087T2 (de) 1993-04-22 1999-07-15 Mitsubishi Chemical Corp., Tokio/Tokyo Wässrige Arzneizubereitungen enthaltend Argatroban und Cyclodextrin oder Coffein
JPH0797325A (ja) 1993-06-30 1995-04-11 Takeda Chem Ind Ltd 安定な固形製剤およびその製造法
AU676315B2 (en) 1993-06-30 1997-03-06 Takeda Chemical Industries Ltd. Stabilized solid pharmaceutical preparation and method of producing the same
HUT72408A (en) 1993-09-10 1996-04-29 Egyt Gyogyszervegyeszeti Gyar Process for producing tablets containing acetyl-salicylic acid
US5641512A (en) 1995-03-29 1997-06-24 The Procter & Gamble Company Soft gelatin capsule compositions
JP3170619B2 (ja) * 1995-04-20 2001-05-28 参天製薬株式会社 有機アミンを配合したプラノプロフェン点眼液
JPH08333265A (ja) 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
JPH08333246A (ja) 1995-06-07 1996-12-17 Taisho Pharmaceut Co Ltd イブプロフェン懸濁液剤
JP3382076B2 (ja) 1995-12-12 2003-03-04 佐藤製薬株式会社 イブプロフェンを溶解してなるかぜ薬軟カプセル及びその製造方法
GB9613457D0 (en) 1996-06-27 1996-08-28 Procter & Gamble Pharmaceutical compositions
US5942508A (en) * 1997-02-04 1999-08-24 Senju Pharmaceutical Co., Ltd. Method for solubilizing pyridonecarboxylic acid solubilizer thereof and aqueous solution containing solubilized pyridonecarboxylic acid

Also Published As

Publication number Publication date
EP1389469B1 (de) 2005-10-26
ATE307610T1 (de) 2005-11-15
KR19980071023A (ko) 1998-10-26
EP0856310A2 (de) 1998-08-05
KR100506484B1 (ko) 2005-11-16
DE69832115T2 (de) 2006-07-13
DE69819569D1 (de) 2003-12-18
EP1389469A1 (de) 2004-02-18
ES2250814T3 (es) 2006-04-16
US20010056098A1 (en) 2001-12-27
EP0856310B1 (de) 2003-11-12
CA2228536A1 (en) 1998-08-04
US6274592B1 (en) 2001-08-14
ATE253891T1 (de) 2003-11-15
US7320985B2 (en) 2008-01-22
EP0856310A3 (de) 2000-01-19
US20050075350A1 (en) 2005-04-07

Similar Documents

Publication Publication Date Title
ATE307610T1 (de) Verfahren zum stabilisieren von arylcarbonsäuren, dafür verwendbarer stabilisator und eine stabilisierte carbonsäure enthaltende wässrige lösung
ES2173499T3 (es) Sales de adicion de acidos de compuesto de piperidina opticamente activo y procedimiento para su preparacion.
ATE511508T1 (de) Verfahren zur kristallisation von (r)- oder (s)- lansoprazol
ATE145910T1 (de) Verfahren zur herstellung von titanderivaten
NO944786L (no) En-kolbe-metode for fremstilling av 3-kinolonkarboksylsyrederivater
NO20005660L (no) Nye mellomprodukter og fremgangsmåter for fremstilling av optisk aktive oktansyrederivater
DK0415102T3 (da) 1,3-Dihydro-1-(pyridinylamino)-2H-indol-2-oner, en fremgangsmåde til deres fremstilling og deres anvendelse som lægemidler
ES504462A0 (es) Procedimiento de tratamiento de insulinas
ATE239505T1 (de) Verfahren zum löslichmachen von pyridoncarbonsäuren mit hilfe von arylcarbonsäuren als lösungsvermittler
ATE172734T1 (de) Verfahren zur herstellung von ceftriaxon
DE60038281D1 (de) Verfahren zur herstellung von optisch aktiven pyridinethanol-derivaten
DE3789409D1 (de) Verfahren zur Herstellung von Chinolin-2,3-Carbonsäure.
ATE205211T1 (de) Benzopyranopyridoncarbonsäuren und verfahren zu ihrer herstellung
DE60026292D1 (de) Eine stabilisierte isothiazolon-zusammensetzung und ein verfahren zur stabilisierung von isothiazolon
ATE215528T1 (de) Verfahren zur herstellung von alpha- aminosäureamide, alpha-aminosäuren und ihre derivaten
DE60019723D1 (de) Eine methode zur herstellung von verbindungen der formel 1 und derivaten
ATE311382T1 (de) Verfahren zur herstellung von 2-carbamoyl- pyridinen
BR9405262A (pt) Processo para a preparação de um ácido piridina-2,3-dicarboxílico
ES2146420T3 (es) Procedimiento para preparar acidos carboxilicos opticamente activos.
PT83715B (pt) Processo para a preparacao de novos derivados de piperidina
ATE247084T1 (de) Verfahren zur herstellung von hydroxamsäuren
HUP9901026A2 (hu) Eljárás N-[2-hidroxi-3-(piperidin-1-il)-propoxi]-oxim éterek optikai izomerjeinek előállítására a racém vegyület reszolválásával, és O-(3-N-piperidino-2-hidroxi-1-propil) nikotinsav-amidoxim (NP51) optikai izomerjei
EP0928791A4 (de) Verfahren zur herstellung von 1,4-benzodioxan-derivaten
DE3872133D1 (de) Verfahren zur herstellung von salzen der dimethylglycylgluconsaeure.
ATE82565T1 (de) Verfahren zur stabilisierung von waessrigen formaldehydloesungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition